日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

CRS or ICANS Are Rare Beyond 2 Weeks After Lisocabtagene Maraleucel Infusion: Data From Clinical Trials and the Real-World Setting

利索卡巴吉内马拉鲁塞输注后2周以上发生细胞因子释放综合征(CRS)或免疫复合物相关神经病变(ICANS)的情况很少见:来自临床试验和真实世界的数据

Hunter, Bradley D; Lunning, Matthew; Shadman, Mazyar; Ahmed, Sairah; Abramson, Jeremy S; Perales, Miguel-Angel; Ahmed, Nausheen; Mirza, Abu-Sayeef; Isufi, Iris; Frigault, Matthew J; Crombie, Jennifer L; Miklos, David B; Vasconcelos, Alberto; Crotta, Alessandro; Bernasconi, David; Roy, Debasmita; Bleickardt, Eric; Pasquini, Marcelo C; Kamdar, Manali

Paediatric Strategy Forum for medicinal product development of chimeric antigen receptor T-cells in children and adolescents with cancer: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration

针对儿童和青少年癌症患者的嵌合抗原受体T细胞药物开发儿科战略论坛:ACCELERATE,与欧洲药品管理局合作,并有美国食品药品监督管理局参与

Pearson, Andrew Dj; Rossig, Claudia; Mackall, Crystal; Shah, Nirali N; Baruchel, Andre; Reaman, Gregory; Ricafort, Rosanna; Heenen, Delphine; Bassan, Abraham; Berntgen, Michael; Bird, Nick; Bleickardt, Eric; Bouchkouj, Najat; Bross, Peter; Brownstein, Carrie; Cohen, Sarah Beaussant; de Rojas, Teresa; Ehrlich, Lori; Fox, Elizabeth; Gottschalk, Stephen; Hanssens, Linda; Hawkins, Douglas S; Horak, Ivan D; Taylor, Danielle H; Johnson, Courtney; Karres, Dominik; Ligas, Franca; Ludwinski, Donna; Mamonkin, Maksim; Marshall, Lynley; Masouleh, Behzad K; Matloub, Yousif; Maude, Shannon; McDonough, Joe; Minard-Colin, Veronique; Norga, Koen; Nysom, Karsten; Pappo, Alberto; Pearce, Laura; Pieters, Rob; Pule, Martin; Quintás-Cardama, Alfonso; Richardson, Nick; Schüßler-Lenz, Martina; Scobie, Nicole; Sersch, Martina A; Smith, Malcolm A; Sterba, Jaroslav; Tasian, Sarah K; Weigel, Brenda; Weiner, Susan L; Zwaan, Christian Michel; Lesa, Giovanni; Vassal, Gilles

Real-world evidence of tisagenlecleucel for pediatric acute lymphoblastic leukemia and non-Hodgkin lymphoma

tisagenlecleucel治疗儿童急性淋巴细胞白血病和非霍奇金淋巴瘤的真实世界证据

Pasquini, Marcelo C; Hu, Zhen-Huan; Curran, Kevin; Laetsch, Theodore; Locke, Frederick; Rouce, Rayne; Pulsipher, Michael A; Phillips, Christine L; Keating, Amy; Frigault, Matthew J; Salzberg, Dana; Jaglowski, Samantha; Sasine, Joshua P; Rosenthal, Joseph; Ghosh, Monalisa; Landsburg, Daniel; Margossian, Steven; Martin, Paul L; Kamdar, Manali K; Hematti, Peiman; Nikiforow, Sarah; Turtle, Cameron; Perales, Miguel-Angel; Steinert, Patricia; Horowitz, Mary M; Moskop, Amy; Pacaud, Lida; Yi, Lan; Chawla, Raghav; Bleickardt, Eric; Grupp, Stephan

Randomized phase 3 study of elotuzumab for relapsed or refractory multiple myeloma: ELOQUENT-2 Japanese patient subanalysis

一项针对复发或难治性多发性骨髓瘤的埃洛妥珠单抗随机3期研究:ELOQUENT-2 日本患者亚组分析

Suzuki, K; Sunami, K; Ohashi, K; Iida, S; Mori, T; Handa, H; Matsue, K; Miyoshi, M; Bleickardt, E; Matsumoto, M; Taniwaki, M

Elotuzumab plus lenalidomide/dexamethasone for relapsed or refractory multiple myeloma: ELOQUENT-2 follow-up and post-hoc analyses on progression-free survival and tumour growth

埃洛妥珠单抗联合来那度胺/地塞米松治疗复发或难治性多发性骨髓瘤:ELOQUENT-2 研究的随访和事后分析,探讨无进展生存期和肿瘤生长情况

Dimopoulos, Meletios A; Lonial, Sagar; White, Darrell; Moreau, Philippe; Palumbo, Antonio; San-Miguel, Jesus; Shpilberg, Ofer; Anderson, Kenneth; Grosicki, Sebastian; Spicka, Ivan; Walter-Croneck, Adam; Magen, Hila; Mateos, Maria-Victoria; Belch, Andrew; Reece, Donna; Beksac, Meral; Bleickardt, Eric; Poulart, Valerie; Sheng, Jennifer; Sy, Oumar; Katz, Jessica; Singhal, Anil; Richardson, Paul

Elotuzumab in combination with lenalidomide and dexamethasone in patients with relapsed multiple myeloma: final phase 2 results from the randomised, open-label, phase 1b-2 dose-escalation study

埃洛妥珠单抗联合来那度胺和地塞米松治疗复发性多发性骨髓瘤患者:一项随机、开放标签、1b-2期剂量递增研究的最终2期结果

Richardson, Paul G; Jagannath, Sundar; Moreau, Philippe; Jakubowiak, Andrzej J; Raab, Marc S; Facon, Thierry; Vij, Ravi; White, Darrell; Reece, Donna E; Benboubker, Lotfi; Zonder, Jeffrey; Tsao, L Claire; Anderson, Kenneth C; Bleickardt, Eric; Singhal, Anil K; Lonial, Sagar